Roles for Intracellular pH Dynamics in Cancer

细胞内 pH 动态在癌症中的作用

基本信息

  • 批准号:
    10121379
  • 负责人:
  • 金额:
    $ 32.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-06-01 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

Abstract Cancers and Alzheimer’s Disease Related Dementias (ADRDs) are increasingly recognized as diseases with dysregulated lysosomes. Although lysosome functions are critically dependent on a lumenal acidic pH of ~ 5.0 for the activity of contained acid-activated hydrolases, whether lysosome pH (pHlys) is dysregulated and a determinant for impaired lysosome functions in cancers and ADRDs has received limited attention. With support from our parent grant CA197856 on intracellular pH dynamics and cancer we generated and validated a new genetically encoded pHlys biosensor, pHLARE (pH Lysosomal Activity REporter), which is the only pHlys sensor that can be propagated in cells for longitudinal studies. We used pHLARE to show a significantly lower pHlys in human cancer cells from different tissue origins and with different mutational signatures compared with tissue- matched untransformed cells, and to identify new pharmacological and genetic approaches to experimentally change pHlys. With funding from our parent grant we are using these new approaches to determine how decreased pHlys enables cancer cell behaviors. Our supplement will use these new approaches developed through our parent grant to address unresolved questions on pHlys in ADRDs, and hence, is ideally suited for NOT-CA-20-019 funding. Our supplement tests the hypothesis that ADRDs have increased pHlys, which decreases the activity of lumenal hydrolases and macromolecular catabolism, leading to increased protein aggregation and neurodegeneration. In Aim 1 we will quantify pHlys in ADRD models expressing pHLARE, including neuroepithelial cells engineered for loss of progranulin and presenilin 1, which are determinants in ADRDs and associated with impaired lysosome function, and neurons differentiated from NHCDR-generated iPSCs derived from patients with identified ADRDs and from unaffected family mutations carriers and non-carriers. In Aim 2 we will determine functional consequences of dysregulated pHlys in ADRD cell models by using pharmacological and genetic approaches we identified in studies in our parent grant that change pHlys. Using the ADRD-associated cell models described in Aim 1 we will to determine the role of pHlys dynamics in protein aggregation, a hallmark of ADRDs, as well as neuronal morphology and lysosome localization and mobility, which are impaired in ADRDs resulting in lysosome-rich enlarged terminal axon swellings. We also will use time-lapse microscopy to determine cell survival, with genetically-encoded pHLARE allowing a new tool for longitudinal studies. Outcomes include resolving the functional consequences of pHlys dynamics and dysregulated lysosome functions in ADRDs. Additionally, our parallel studies on pHlys in cancer (parent grant) and ADRDs (supplement) have promise to identify new therapeutic approaches targeting dysregulated pHlys to limit the progression of these diseases.
摘要 癌症和阿尔茨海默病相关痴呆(ADRD)越来越被认为是一种 调节失调的溶酶体。尽管溶酶体的功能严重依赖于管腔酸性pH~5.0 对于所含的酸激活水解酶的活性,溶酶体的pH(PHlys)是否失调,以及 癌症和ADRD中溶酶体功能受损的决定因素受到的关注有限。有了支持 从我们的父母授予的关于细胞内pH动态和癌症的CA197856,我们产生并验证了一个新的 基因编码的PHLYS生物传感器,PHLARE(pH溶酶体活性报告),这是唯一的PHLYS传感器 可以在细胞中繁殖以进行纵向研究。我们使用PHLARE显示了显著较低的PHLYS 人类癌细胞来自不同的组织来源,与组织相比具有不同的突变特征- 匹配未转化的细胞,并确定新的药理学和遗传学方法来进行实验 换个PHLYS。在我们母公司的资助下,我们正在使用这些新的方法来确定如何 PHLys的降低使癌细胞的行为得以实现。我们的增刊将使用这些开发的新方法 通过我们的母公司拨款解决ADRDS中尚未解决的PHLYS问题,因此非常适合 不是-CA-20-019资金。我们的补充检验了ADRDS使PHlys升高的假设,这一假设 降低管腔水解酶活性和大分子分解代谢,导致增加 蛋白质聚集和神经退行性变。在目标1中,我们将量化ADRD模型中的PHLY PHLARE,包括专为丢失前颗粒蛋白和早老素1而设计的神经上皮细胞,它们是 ADRD中的决定因素与溶酶体功能受损相关,以及神经元分化为 NHCDR产生的IPSCs来自已确诊的ADRD患者和未受影响的家系突变 承运人和非承运者。在目标2中,我们将确定ADRD中调节失调的PHLys的功能后果 通过使用我们在父母资助的研究中确定的药理学和遗传学方法建立细胞模型 换个PHLYS。使用目标1中描述的ADRD相关细胞模型,我们将确定pHlys的作用 ADRDS的标志蛋白质聚集的动力学,以及神经元形态和溶酶体 ADRDS的定位和移动性受损,导致富含溶酶体的终末轴突增大 肿胀。我们还将使用延时显微镜来确定细胞存活,并使用基因编码的PHLARE 为纵向研究提供了一种新的工具。结果包括解决PHLYS的功能后果 ADRDS的动力学和溶酶体功能失调。此外,我们对PHLys在癌症中的平行研究 (父母资助)和ADRDS(补充)承诺确定新的治疗方法 调节失调的PHLys,以限制这些疾病的进展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DIANE L BARBER其他文献

DIANE L BARBER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DIANE L BARBER', 18)}}的其他基金

Regulation of transcription factor activity in neural crest development by pH dynamics
pH 动态对神经嵴发育中转录因子活性的调节
  • 批准号:
    10508784
  • 财政年份:
    2022
  • 资助金额:
    $ 32.02万
  • 项目类别:
Regulation of transcription factor activity in neural crest development by pH dynamics
pH 动态对神经嵴发育中转录因子活性的调节
  • 批准号:
    10656499
  • 财政年份:
    2022
  • 资助金额:
    $ 32.02万
  • 项目类别:
Roles for Intracellular pH Dynamics in Cancer
细胞内 pH 动态在癌症中的作用
  • 批准号:
    9105668
  • 财政年份:
    2016
  • 资助金额:
    $ 32.02万
  • 项目类别:
Roles for Intracellular pH Dynamics in Cancer
细胞内 pH 动态在癌症中的作用
  • 批准号:
    9906489
  • 财政年份:
    2016
  • 资助金额:
    $ 32.02万
  • 项目类别:
Roles for Intracellular pH Dynamics in Cancer
细胞内 pH 动态在癌症中的作用
  • 批准号:
    9275934
  • 财政年份:
    2016
  • 资助金额:
    $ 32.02万
  • 项目类别:
Roles for Intracellular pH Dynamics in Cancer
细胞内 pH 动态在癌症中的作用
  • 批准号:
    9487198
  • 财政年份:
    2016
  • 资助金额:
    $ 32.02万
  • 项目类别:
Roles for Intracellular pH Dynamics in Cancer
细胞内 pH 动态在癌症中的作用
  • 批准号:
    10659948
  • 财政年份:
    2016
  • 资助金额:
    $ 32.02万
  • 项目类别:
Roles for Intracellular pH Dynamics in Cancer
细胞内 pH 动态在癌症中的作用
  • 批准号:
    10469119
  • 财政年份:
    2016
  • 资助金额:
    $ 32.02万
  • 项目类别:
Regulation of Epithelial Plasticity
上皮可塑性的调节
  • 批准号:
    9103387
  • 财政年份:
    2015
  • 资助金额:
    $ 32.02万
  • 项目类别:
Regulation of Epithelial Plasticity
上皮可塑性的调节
  • 批准号:
    8888935
  • 财政年份:
    2015
  • 资助金额:
    $ 32.02万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.02万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.02万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.02万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.02万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.02万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.02万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.02万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.02万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.02万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.02万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了